Skinvisible Statistics
Skinvisible (SKVI) Stock Statistics & Valuation Metrics
Total Valuation
Skinvisible has a market cap or net worth of $972.69K. The enterprise value is $6.87T.
- Market Cap
- $972.69K
- Enterprise Value
- $6.87T
Share Statistics
Skinvisible has 5,403,843 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,403,843
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Skinvisible’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 10.94%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- -8.34
- Return on Invested Capital (ROIC)
- 10.94%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 10.00K
- Profits Per Employee
- -532.02K
- Employee Count
- 2
- Asset Turnover
- 0.16
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Skinvisible is -0.92. Skinvisible’s PEG ratio is 0.01.
- PE Ratio
- -0.92
- PS Ratio
- 45.96
- PB Ratio
- -0.09
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Skinvisible had revenue of 20.00K and earned -1.06M in profits. Earnings per share was -0.20.
- Revenue
- 20.00K
- Gross Profit
- -239
- Operating Income
- -496.31K
- Pretax Income
- -1.06M
- Net Income
- -1.06M
- EBITDA
- -471.55K
- Earnings Per Share (EPS)
- -0.20
Cash Flow
In the last 12 months, operating cash flow was -38.41B and capital expenditures 0, giving a free cash flow of -38.41B billion.
- Operating Cash Flow
- -38.41B
- Free Cash Flow
- -38.41B
- Free Cash Flow per Share
- -7107.91
Dividends & Yields
Skinvisible pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3948840.24%
- Earnings Yield
- -106.59%
Stock Price Statistics
- Beta
- 0.21
- 52-Week Price Change
- -48.57%
- 50-Day Moving Average
- 0.19
- 200-Day Moving Average
- 0.24
- Relative Strength Index (RSI)
- 52.54
- Average Volume (3m)
- 1,145
Financial Position
Skinvisible as a current ratio of 0.01, with Debt / Equity ratio of -55.78%
- Current Ratio
- 0.01
- Quick Ratio
- 0.01
- Debt to Market Cap
- 4.60
- Net Debt to EBITDA
- -12.13
- Interest Coverage Ratio
- -0.87
Taxes
In the past 12 months, Skinvisible has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Skinvisible EV to EBITDA ratio is -15.10, with an EV/FCF ratio of -0.00.
- EV to Sales
- 316.68
- EV to EBITDA
- -15.10
- EV to Free Cash Flow
- -0.00
- EV to Operating Cash Flow
- -0.00
Balance Sheet
Skinvisible has $3,959.00 in cash and marketable securities with $5.72M in debt, giving a net cash position of -$5.72M billion.
- Cash & Marketable Securities
- $3,959.00
- Total Debt
- $5.72M
- Net Cash
- -$5.72M
- Net Cash Per Share
- -$1.06
- Tangible Book Value Per Share
- -$2.01
Margins
Gross margin is 4.38%, with operating margin of -2193.71%, and net profit margin of -4898.22%.
- Gross Margin
- 4.38%
- Operating Margin
- -2193.71%
- Pretax Margin
- -4898.22%
- Net Profit Margin
- -4898.22%
- EBITDA Margin
- -2097.77%
- EBIT Margin
- -1667.41%
Analyst Forecast
The average price target for Skinvisible is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 5.83%
- EPS Growth Forecast
- -112.51%

